000 01300 a2200361 4500
005 20250515085603.0
264 0 _c20080117
008 200801s 0 0 eng d
022 _a1778-7254
024 7 _a10.1016/j.jbspin.2007.04.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSoubrier, Martin
245 0 0 _aAtheroma and systemic lupus erythematosus.
_h[electronic resource]
260 _bJoint bone spine
_cDec 2007
300 _a566-70 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntimalarials
_xadverse effects
650 0 4 _aAtherosclerosis
_xetiology
650 0 4 _aCalcinosis
_xetiology
650 0 4 _aCarotid Arteries
_xpathology
650 0 4 _aCoronary Artery Disease
_xetiology
650 0 4 _aCoronary Vessels
_xmetabolism
650 0 4 _aGlucocorticoids
_xadverse effects
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xtherapeutic use
650 0 4 _aLupus Erythematosus, Systemic
_xcomplications
650 0 4 _aRisk Factors
650 0 4 _aTunica Intima
_xpathology
700 1 _aMathieu, Sylvain
700 1 _aDubost, Jean-Jacques
773 0 _tJoint bone spine
_gvol. 74
_gno. 6
_gp. 566-70
856 4 0 _uhttps://doi.org/10.1016/j.jbspin.2007.04.006
_zAvailable from publisher's website
999 _c17396761
_d17396761